Merit Medical Systems (MMSI) Cash & Equivalents (2009 - 2026)

Merit Medical Systems has disclosed Cash & Equivalents across 18 years of filings, most recently posting $488.1 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $488.1 million, up 23.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $488.1 million (up 23.4% YoY), and the FY2025 annual result was $446.4 million, up 18.5% from the prior year.
• Cash & Equivalents came in at $488.1 million for Q1 2026 at Merit Medical Systems, up from $446.4 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $636.7 million in Q2 2024 to a low of $51.5 million in Q3 2022.
• The 5-year median for Cash & Equivalents is $376.7 million (2024), against an average of $305.0 million.
• Across the five-year window, Cash & Equivalents surged 905.06% in 2023 and slumped 46.31% in 2025, its largest moves.
• Merit Medical Systems' Cash & Equivalents stood at $58.4 million in 2022, then soared by 905.06% to $587.0 million in 2023, then sank by 35.83% to $376.7 million in 2024, then grew by 18.5% to $446.4 million in 2025, then increased by 9.34% to $488.1 million in 2026.
• The last three Cash & Equivalents figures came in at $488.1 million (Q1 2026), $446.4 million (Q4 2025), and $392.5 million (Q3 2025), per Business Quant data.